KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $2.6 million.

  • Teladoc Health's Depreciation & Amortization (CF) fell 202.55% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 3499.4%. This contributed to the annual value of $10.2 million for FY2024, which is 857.43% down from last year.
  • Teladoc Health's Depreciation & Amortization (CF) amounted to $2.6 million in Q3 2025, which was down 202.55% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Teladoc Health's Depreciation & Amortization (CF) registered a high of $94.3 million during Q3 2023, and its lowest value of $1.7 million during Q2 2024.
  • For the 5-year period, Teladoc Health's Depreciation & Amortization (CF) averaged around $38.1 million, with its median value being $51.3 million (2021).
  • In the last 5 years, Teladoc Health's Depreciation & Amortization (CF) soared by 41896.29% in 2021 and then plummeted by 9774.33% in 2024.
  • Over the past 5 years, Teladoc Health's Depreciation & Amortization (CF) (Quarter) stood at $52.3 million in 2021, then skyrocketed by 44.68% to $75.7 million in 2022, then crashed by 96.31% to $2.8 million in 2023, then increased by 6.7% to $3.0 million in 2024, then decreased by 12.35% to $2.6 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $2.6 million for Q3 2025, versus $4.3 million for Q2 2025 and $3.6 million for Q1 2025.